Overview
Jingzhen Du practices practicing medicine in Manchester, United Kingdom.
Du is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Virus Associated Hemophagocytic Syndrome, Peripheral T-Cell Lymphoma, and Non-Hodgkin Lymphoma.
They are actively involved in clinical research, co-authoring 23 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jingzhen W. Du
Is Jingzhen W. Du a top-rated expert for Virus Associated Hemophagocytic Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Jingzhen W. Du is classified as an Advanced expert for Virus Associated Hemophagocytic Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jingzhen W. Du participate in research or clinical trials?
Yes. Jingzhen W. Du has published 23 articles and abstracts on conditions like Virus Associated Hemophagocytic Syndrome. You can view a list of Jingzhen W. Du's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Virus Associated Hemophagocytic Syndrome
- Experienced
- Non-Hodgkin LymphomaDu isExperienced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell Lymphoma